Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-09-14
1984-07-31
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
252107, 424 59, 424 73, 424168, 424177, 424358, 424361, 424365, 426 42, A61K 715, A61K 742, A61K 4700
Patent
active
044630174
ABSTRACT:
The invention relates to a composition for topical administration. This composition contains an active proportion, namely from 0.5 to 25% by weight and preferably from 2 to 10% by weight, of a hydrolysate of lactalbumin obtained solely by the action of an endopeptidase, said hydrolysate consisting essentially of peptides having a molecular weight of from 200 to 5000.
This composition may be used as a cosmetic or therapeutic agent.
REFERENCES:
patent: 597378 (1898-01-01), Backhaus
patent: 2023359 (1935-12-01), Sirek
patent: 2585225 (1952-02-01), Carlson
patent: 4076800 (1978-02-01), Marsh et al.
patent: 4179333 (1979-12-01), Braeumer et al.
patent: 4209503 (1980-06-01), Shah
Burnett, Amer. Perf. & Cosm., 10/63 vol. 78, pp. 69-72.
Derwent Abstract No. 457353/25, 5/6/78, Zimzik.
Hidalgo Jaime
Jost Rolf
Ore Dale R.
Societe d'Assistance Technique pour Produits Nestle S.A.
LandOfFree
Composition for topical administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for topical administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for topical administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-185526